1. Home
  2. Company search

Company search

KOBE Life Science Cluster Company List

Business Expansion
on Kobe's Port Island

341

companies

as of July 31, 2025

Companies are divided into categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the minor field.» List of KBIC companies(PDF)

≫ StartupsStartups Company List

Search by Company name or Keyword

Business sector search results Regenerative Medicine

1 10of Results 33

Re-search in Business sector

Major field

Minor field

Company name

Business outline

Regenerative Medicine
Production of Drugs and Quasi Drugs
Air Water Aeras Bio Inc.
Development of dental pulp stem cell technologies and marketing of oral care products
Regenerative Medicine
Drug Discovery Production of Drugs and Quasi Drugs
AlliedCel Corporation
Other
Genomics Regenerative Medicine
Biologics Center for Research and Training
Development of human resources and provision of support for R&D activities in the field of biologics
Regenerative Medicine
Drug Discovery
CynosBio, Inc.
Development, manufacturing, and marketing of regenerative medicine products
Regenerative Medicine
Contract Research Production of Drugs and Quasi Drugs
Cyto-Facto Inc.
Specialized in manufacturing cell and gene products as CDMO
Production Equipment
Regenerative Medicine Production of Drugs and Quasi Drugs
DAIKIN APPLIED SYSTEMS CO.,LTD
Total engineering from construction and maintenance of factories and CPC in the field of drugs and cell culturing
Production Equipment
Regenerative Medicine Genomics
Double Helix International, Inc.
Development of regenerative medicine-related devices
Distributor
Regenerative Medicine Production of Drugs and Quasi Drugs
FUJI CHEMICALS LTD.
Sales of reagents and devices related to physics and chemistry
Diagnostic Agent and Device
Regenerative Medicine Genomics
GSP Lab., Inc.
Development, production, and sales of companion diagnostics
Regenerative Medicine
HEALIOS K.K.
Research, development, manufacture of cell therapy products and regenerative medicine products
  1. 1
  2. 2
  3. 3
  4. 4
  5. >

Location search results

1 10of Results 33

Re-search in Location

Major field

Miner field

Company name

Business outline

Regenerative Medicine
Production of Drugs and Quasi Drugs
Air Water Aeras Bio Inc.
Development of dental pulp stem cell technologies and marketing of oral care products
Regenerative Medicine
Drug Discovery Production of Drugs and Quasi Drugs
AlliedCel Corporation
Other
Genomics Regenerative Medicine
Biologics Center for Research and Training
Development of human resources and provision of support for R&D activities in the field of biologics
Regenerative Medicine
Drug Discovery
CynosBio, Inc.
Development, manufacturing, and marketing of regenerative medicine products
Regenerative Medicine
Contract Research Production of Drugs and Quasi Drugs
Cyto-Facto Inc.
Specialized in manufacturing cell and gene products as CDMO
Production Equipment
Regenerative Medicine Production of Drugs and Quasi Drugs
DAIKIN APPLIED SYSTEMS CO.,LTD
Total engineering from construction and maintenance of factories and CPC in the field of drugs and cell culturing
Production Equipment
Regenerative Medicine Genomics
Double Helix International, Inc.
Development of regenerative medicine-related devices
Distributor
Regenerative Medicine Production of Drugs and Quasi Drugs
FUJI CHEMICALS LTD.
Sales of reagents and devices related to physics and chemistry
Diagnostic Agent and Device
Regenerative Medicine Genomics
GSP Lab., Inc.
Development, production, and sales of companion diagnostics
Regenerative Medicine
HEALIOS K.K.
Research, development, manufacture of cell therapy products and regenerative medicine products
  1. 1
  2. 2
  3. 3
  4. 4
  5. >

You can select the initial.

Initial search results

1 10of Results 33

Re-search in Initial

Major field

Miner field

Company name

Business outline

Regenerative Medicine
Production of Drugs and Quasi Drugs
Air Water Aeras Bio Inc.
Development of dental pulp stem cell technologies and marketing of oral care products
Regenerative Medicine
Drug Discovery Production of Drugs and Quasi Drugs
AlliedCel Corporation
Other
Genomics Regenerative Medicine
Biologics Center for Research and Training
Development of human resources and provision of support for R&D activities in the field of biologics
Regenerative Medicine
Drug Discovery
CynosBio, Inc.
Development, manufacturing, and marketing of regenerative medicine products
Regenerative Medicine
Contract Research Production of Drugs and Quasi Drugs
Cyto-Facto Inc.
Specialized in manufacturing cell and gene products as CDMO
Production Equipment
Regenerative Medicine Production of Drugs and Quasi Drugs
DAIKIN APPLIED SYSTEMS CO.,LTD
Total engineering from construction and maintenance of factories and CPC in the field of drugs and cell culturing
Production Equipment
Regenerative Medicine Genomics
Double Helix International, Inc.
Development of regenerative medicine-related devices
Distributor
Regenerative Medicine Production of Drugs and Quasi Drugs
FUJI CHEMICALS LTD.
Sales of reagents and devices related to physics and chemistry
Diagnostic Agent and Device
Regenerative Medicine Genomics
GSP Lab., Inc.
Development, production, and sales of companion diagnostics
Regenerative Medicine
HEALIOS K.K.
Research, development, manufacture of cell therapy products and regenerative medicine products
  1. 1
  2. 2
  3. 3
  4. 4
  5. >

Air Water Aeras Bio Inc.

Major field: Regenerative Medicine

Miner field: Production of Drugs and Quasi Drugs

Development of dental pulp stem cell technologies and marketing of oral care products

Overview

As a subsidiary of Air Water Group that has expanded its business from industrial gas to medical and dental related field. Air Water Aeras Bio was founded to promote application of dental pulp stem cell technology.

Product / Service / PR

    In recent years oral health has received more attention for its link to body health. Above all, one of the key to prolong healthy lifespan is to keep your own tooth as long as possible. Aeras Bio is establishing a new therapy for treating severe cavities and pulpitis. Dental pulp regenerative therapy revives dental pulp by taking dental pulp stem cell from unwanted tooth in orthodontic treatment or wisdom tooth, then transplant the stem cell to tooth after pulp extraction (root canal), subsequently regenerate the dental pulp. In addition to clinical research in pulp regeneration and enamel regeneration, Aeras Bio is concurrently working on cell extraction, cell culture, preservation and transportation of dental pulp stem cell from unwanted tooth.
Address: 1-3-1, Minatojima-minamimachi, Chuo-ku, Kobe, 650-0047 JAPAN  (Contact Person  Misaki Kawamoto)
TEL: +81-78-303-0031 FAX: +81-78-303-0031
Web site: https://aerasbio.co.jp/ E-mail: info-aerasbio-h@awi.co.jp

AlliedCel Corporation

Major field: Regenerative Medicine

Miner field: Drug Discovery

Miner field: Production of Drugs and Quasi Drugs

Biologics Center for Research and Training

Major field: Other

Miner field: Genomics

Miner field: Regenerative Medicine

Development of human resources and provision of support for R&D activities in the field of biologics

Address: Integrated Research Center of Kobe University Annex Bldg. 401 7-1-49 Minatojima Minamimachi, Chuo-ku, Kobe, 650-0047, Japan  (Contact Person  Hideo Nogusa)
TEL: 078-302-0123 FAX: 078-599-6087
Web site: https://www.bcret.jp E-mail: hideo.nogusa@bcret.jp

CynosBio, Inc.

Major field: Regenerative Medicine

Miner field: Drug Discovery

Development, manufacturing, and marketing of regenerative medicine products

Overview

Development, manufacturing and supply of regenerative and other medical products

Product / Service / PR

    CynosBio, Inc. is the first unlisted domestic company to commercialize regenerative medicine products.
    Under the bridging research led by the Foundation for Biomedical Research and Innovation at Kobe (FBRI), the company is engaged in the development, manufacturing, and sales of regenerative medicine products introduced from academia (such as university hospitals).
    In 2022, the company achieved the approval and insurance listing of the oral mucosa-derived epithelial cell sheet "TR-9 (Sakuracy®)" using amniotic membrane matrix, a product researched at Kyoto Prefectural University of Medicine. This achievement has provided a new treatment for diseases that were previously difficult to treat.
    Currently, the company is focused on the development of a treatment for osteoarthritis of the knee using the autologous cartilage cell processing product "IK-01." The disease, which is said to affect approximately 25 million people, including potential patients in Japan, is the target of corporate clinical trials.
    The company will continue to focus on technological innovation in regenerative medicine and research in cell culture technologies, striving to offer innovative treatments utilizing the power of regenerative medicine for diseases that are difficult to treat.
Address: 1-3-15 Nihonbashi Horidome-cho, Chuo-ku, TOKYO, JAPAN.  (Contact Person  Kousuke Oota)
TEL: +81-36-457-9861 FAX: +81-36-261-4445
Web site: https://cynosbio.com/about/ E-mail: info.tokyo@cynosbio.com

Cyto-Facto Inc.

Major field: Regenerative Medicine

Miner field: Contract Research

Miner field: Production of Drugs and Quasi Drugs

Specialized in manufacturing cell and gene products as CDMO

Overview

Services we provide in the field of cell & gene therapy
1. Contracted manufacturing of commercial products (CMO)
2. Process development and manufacturing of clinical products (CDMO)
3. Quality control testing of CGT products for commercial, clinical and research use
4. Development, sales, and service business of manufacturing management systems
5. Consultation for regulatory issues

Product / Service / PR

    Cyto-Facto (its predecessor, the RDC of the FBRI) is the first Asian company to manufacture commercial CAR-T products in compliance with PIC/S GMP. Cyto-Facto has accumulated experience in manufacturing technology know-how and has launched several cell & gene manufacturing pipelines, including CAR-T, iPSC-based cells and mesenchymal stem cells (MSCs) of various developmental stages.
Address: Shimin Byoin Mae Bldg. 3F, 2-1-11 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047 Japan  (Contact Person  General Affairs and Human Resources)
TEL: +81-78-306-0681
Web site: https://www.cytofacto.com/eng/ E-mail: info@cytofacto.com

DAIKIN APPLIED SYSTEMS CO.,LTD

Major field: Production Equipment

Miner field: Regenerative Medicine

Miner field: Production of Drugs and Quasi Drugs

Total engineering from construction and maintenance of factories and CPC in the field of drugs and cell culturing

Double Helix International, Inc.

Major field: Production Equipment

Miner field: Regenerative Medicine

Miner field: Genomics

Development of regenerative medicine-related devices

Overview

Double Helix International, Inc. represents major players of single use system manufactures in the US and Europe including but not limited to SaniSure, Inc., AdvantaPure from New Age Industries, Inc., PendoTECH,Inc., UFPTehcnologies, Inc. CharterMedical, Inc.. Cellon, S.A., FabOhio and Terracon Corporation.

Address: IMDA 5th Fl., 1-6-5 Minatojima-Minamimachi, Cyuoh-ku, Kobe 650-0047 Japan  (Contact Person  Yukino Kanda)
TEL: +81-78-335-6805 FAX: +81-78-335-6806
Web site: http://www.d-helixintl.com E-mail: info@d-helixintl.com

FUJI CHEMICALS LTD.

Major field: Distributor

Miner field: Regenerative Medicine

Miner field: Production of Drugs and Quasi Drugs

Sales of reagents and devices related to physics and chemistry

GSP Lab., Inc.

Major field: Diagnostic Agent and Device

Miner field: Regenerative Medicine

Miner field: Genomics

Development, production, and sales of companion diagnostics

Overview

More than 300 kinds of development of a FISH probe, production and sale are being performed from 200,000 kinds of BAC clone built originally.
The product in which the cancer relation, genetic abnormal of diagnosis preimplantation and regenerative medicine (iPS cell) are detected has been often developed.
These products are also used by foreign countries, not only the country and appear on a paper beyond 120 reports.

Product / Service / PR

    Chromosomal abnormal is detected.
    Amplification and translocate of a cancer related gene are detected.
    The chromosome number-like abnormality of preimplantation cell is detected.
    The chromosome number-like abnormality of ES and iPS cell is detected.
Address: Kobe KIMEC Center Bldg. 6F, 1-5-2Minatojima-Minamimachi Chyo-ku Kobe, Hyogo, 650-0047 Japan  (Contact Person  Masahiko Maekawa)
TEL: +81-78-599-8635 FAX: +81-78-599-8636
Web site: http://www.gsplab.co.jp/ E-mail: info@gsplab.co.jp

HEALIOS K.K.

Major field: Regenerative Medicine

Research, development, manufacture of cell therapy products and regenerative medicine products

Overview

Raising our mission, “To be the change in an ever evolving world through enrichment of living”, HEALIOS was established in 2011 via Riken Venture system.
We are dedicated to develop promising medicines to heal and bring hope to those worldwide who are suffering from incurable diseases by making use of the regenerative power.

Product / Service / PR

    [Somatic stem cell regenerative medicine]
    Development of regenerative medicine for ischemic stroke and Acute Respiratory Distress Sydrome (ARDS) in Japan using MultiStem®, products developed by Athersys, Inc.
    [iPSC regenerative medicine]
    Development of Treatments for Age-Related Macular Degeneration (AMD) involving transplantation of iPS cell-derived retinal pigment epithelial (RPE) cells.
    Development of Organ Bud Transplantation Therapy involving a technology to create functional human organs using iPS cells.
Address: Kobe KIMEC Center Building 3F, 1-5-2 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan 
Web site: https://www.healios.co.jp/en/ E-mail: info@healios.jp